Jennifer (Jenn) Garson was born and raised in Madison, WI. She received her Doctor of Pharmacy degree from Purdue University in West Lafayette, Indiana. To augment her residency training at DUH, she is completing a Master of Science in Pharmaceutical Sciences with a specialization in Health-System Pharmacy Administration through the University of North Carolina. Notable longitudinal experiences within Dr. Garson’s residency include chairing the DUHS Formulary and Informatics Subcommittee, serving on the DUH Children’s P&T Committee, and managing the Clinical Intern Program. Her research involves implementing and evaluating an inpatient medication access program for patients prior to discharge. Dr. Garson is also passionate about national pharmacy involvement and currently serves as the Chair of the PAL Resident Resources Workgroup for ASHP's Pharmacy Administration and Leadership Resident Collaborative. In the future, she hopes to attain a pharmacy leadership position aligned with her administrative interests of clinical management, transitions of care, and global health. In her free time, Dr. Garson enjoys visiting friends and family across the country, trying new foods, and cheering on Boilermaker athletics.
Nataliya Shamanska is originally from Ternopil, Ukraine. She received her Doctor of Pharmacy degree from the Eshelman School of Pharmacy at Chapel Hill. While completing her two-year residency, she will also complete a Master of Science in Pharmaceutical Sciences with a specialization in Health-System Pharmacy Administration through the University of North Carolina. Her clinical practice interests include oncology and cardiology, and her administrative interests include clinical management, informatics, finance and budgeting. In addition to her clinical responsibilities, Dr. Shamanska serves on the Internal and Specialty Medicine Formulary Evaluation Team and is completing the Teaching and Precepting Certificate Program. Her research will evaluate IVIG dose escalation and admissions for Myasthenia Gravis patients for earlier initiation of rovulizumab-cwvz, and her capstone project will evaluate the use of Artificial Intelligence to support comprehensive medication management. In the future, Dr. Shamanska wishes to attain a pharmacy leadership position that will allow her to contribute to the development of innovative strategies in pharmacy practice and advance the field through both clinical excellence and strategic oversight.